Consistently, using the somatic mutation data, we discovered some cancer processes, such as “PI3K-Akt signaling pathway”, “VEGF signaling pathway”, “ECM–receptor interaction”, and “Cellular senescence”, were significantly enriched in the high-risk group (Figure 9C), which verified more cancer-related mutations happen in the group with high risk. The gene discussed is VEGFA; the disease is cancer.